Every 2.3 seconds, a baby needs jaundice treatment—affecting 14 million newborns each year. If left untreated, severe jaundice can lead to neurological damage. Current treatments often mean separation, incubators, and stress for both babies and parents.
Nurses struggle with staff shortages. And health systems spend billions treating jaundice inefficiently, even though these babies aren’t sick.
Bilihome began when Rick, our COO, could only watch his son Thijs, separated from is mum, and his twin sister. His story—along with countless others— continues fueling our mission of Zero Separation.
Bilihome’s patented wearable phototherapy integrates hospital-grade blue light therapy into a soft, organic cotton romper. No incubators, no eye masks, no separation. Parents can soothe, hold, feed, and bond with their newborns while effective treatment continues.
Bilihome is clinically proven and carefully designed with parents and newborn care in mind. From diaper changes to breastfeeding, parents can easily and safely care for their newborn at home and in the hospital during treatment. No complex setup, just effective treatment that seamlessly fits into newborn care.
Our technology is rigorously tested with and for healthcare professionals. Bilihome’s innovation provides hospital-grade treatment while supporting newborn care.
Bilihome can be used in the NICU, maternity ward, and at home—freeing up hospital beds while maintaining high-quality care. Healthcare teams can reduce staff workload, and parents can provide care with confidence.
Bilihome B.V.
Van Siburgstraat 34
3863 HW Nijkerk
The Netherlands
KVK: 75075938
VAT: NL860132109B01
Copyright © 2025 bilihome B.V.
Bilihome B.V.
Van Siburgstraat 34
3863 HW Nijkerk
The Netherlands
KVK: 75075938
VAT: NL860132109B01
Copyright © 2025 bilihome B.V.